Report Summary

The global pharmaceutical market is expected to earn over a trillion dollar in revenues by 2012 and according to "Global Pharmaceutical Market Forecast to 2012", our new research report, the market will witness a number of changes impacting its course of growth. These include the shift of growth from the developed markets to the emerging ones, increasing focus on biotech-based drugs, fewer new drug approvals, and a strong growth in the prevalence of generics.

This report, an updated and far more exhaustive and analytical version of our popular 2006 study, provides a comprehensive analysis of every major pharmaceutical market worldwide. Thirty-four major pharmaceutical markets from North America, Latin America, Europe, Asia-Pacific and Africa have been selected as the most important regions to be presented in this report. Factual insight, supplemented with statistical overview on the past, present and future, together with statistics and analysis pertaining to market size, growth, segmentation, government policies, healthcare indicators, key players, health coverage, new developments and future prospects has been provided for each market.

"Global Pharmaceutical Market Forecast to 2012¡± acts as a valuable tool for pharmaceutical manufactures/investors/consultants who are studying the global pharmaceutical market as it helps in identifying and analyzing market opportunities that will suit their business needs and profiles.

Key Research Findings

Growing at a CAGR of around 8%, the global pharmaceutical market is forecasted to reach US$ 1043.4 Billion in 2012.
North America remains the largest pharmaceutical market constituting 42.8% of the global sales in 2007. Growth in the region is however expected to slow down in near future owing to patent expiration of key drugs and increased prevalence of generics.
In Europe, growth in the top five markets is expected to remain sluggish in next five years. Emerging markets in Central and Eastern Europe is however expected to drive growth in future.
A large untapped population and strong economic growth in major countries is expected to make Asia-Pacific the most lucrative pharmaceutical market in future.
Growth in the Latin American markets is expected to be strong with Brazil and Mexico amongst the most emerging pharmaceutical markets in the world.
Dwindling drug pipelines and patent expiration of a number of blockbuster drugs may challenge the growth of global pharmaceutical market in future.

Key Players Discussed in the Report

This section provides the overview, key facts, strengths and weaknesses, and financial information of prominent players in the global pharmaceutical market like Pfizer Inc, Sanofi-Aventis, GlaxoSmithKline Plc and AstraZeneca Plc.

Key Issues and Facts Analyzed in the Report

What are the emerging trends in the global pharmaceutical sector?
What are the future prospects of the pharmaceutical industry in various regions across the world?
What opportunities exist for the industry?
What challenges are being faced by the industry?
Who are the key players in the global pharmaceutical market?

Research Methodology Used

Information Sources
Information has been sourced from various credible sources like books, newspapers, trade journals, white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.

Analysis Methods
RNCOS industry forecast and analysis is based on various macro- and microeconomic factors, sector and industry specific databases, and our in-house statistical and analytical model. This model takes into account the past and current trends in an economy, and more specifically in an industry, to bring out an objective market analysis.

Our industry experts study the relationship between various industry and economic variables to ensure the required accuracy and desired check on the quality of data and information given in the report.

Report Outline

1. Analyst View
2. Global Pharmaceutical Market: An Overview
2.1 Market Size & Growth
2.2 Geographical Performance
2.3 Leading Therapy Classes
2.4 Leading Drugs
2.5 Leading Pharmaceutical Companies
3. Market by Region
3.1 North America
3.1.1 US
3.1.2 Canada
3.2 Latin America
3.2.1 Brazil
3.2.2 Mexico
3.2.3 Argentina
3.2.4 Chile
3.3 Europe
3.3.1 Germany
3.3.2 France
3.3.3 Italy
3.3.4 Spain
3.3.5 UK
3.3.6 Russia
3.3.7 Turkey
3.3.8 Poland
3.3.9 Hungary
3.3.10 Ukraine
3.3.11 Czech Republic
3.3.12 Romania
3.4 Asia-Pacific
3.4.1 India
3.4.2 China
3.4.3 Japan
3.4.4 South Korea
3.4.5 Indonesia
3.4.6 Vietnam
3.4.7 Thailand
3.4.8 Philippines
3.4.9 Malaysia
3.4.10 Saudi Arabia
3.4.11 UAE
3.4.12 Australia
3.4.13 New Zealand
3.5 Africa
3.5.1 South Africa
3.5.2 Egypt
3.5.3 Nigeria
4. Key Player Profiles
4.1 Pfizer Inc
4.2 Sanofi-Aventis
4.3 GlaxoSmithKline plc
4.4 Novartis International AG
4.5 AstraZeneca Plc

Figures

Figure 2-1: Global - Pharmaceutical Market (in Billion US$), 2002-2007
Figure 2-2: Global - Growth in Pharmaceutical Market (%), 2002-2007
Figure 2-3: Global - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 2-4: Global - Pharmaceutical Market by Region (%), 2007
Figure 2-5: Global - Leading Pharmaceutical Companies by Sales & Net Income (in Billion US$), 2007
Figure 3-1: North America - Pharmaceutical Market (in Billion US$), 2006 & 2007
Figure 3-2: North America - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-3: US - Pharmaceutical Market (in Billion US$), 2006 & 2007
Figure 3-4: US - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-5: Canada - Pharmaceutical Market (in Billion C$), 2003-2007
Figure 3-6: Canada - Forecast for Pharmaceutical Market (in Billion C$), 2008-2012
Figure 3-7: Latin America - Pharmaceutical Market (in Billion US$), 2006 & 2007
Figure 3-8: Latin America - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-9: Brazil - Pharmaceutical Market (in Billion R$), 2006 & 2007
Figure 3-10: Brazil - Forecast for Pharmaceutical Market (in Billion R$), 2008-2012
Figure 3-11: Mexico - Pharmaceutical Market (in Billion US$), 2006 & 2007
Figure 3-12: Mexico - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-13: Argentina - Pharmaceutical Market (in Billion US$), 2003-2007
Figure 3-14: Argentina - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-15: Chile - Pharmaceutical Market (in Billion US$), 2003-2007
Figure 3-16: Chile - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-17: Europe - Pharmaceutical Market (in Billion US$), 2006 & 2007
Figure 3-18: Europe - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-19: Germany - Pharmaceutical Market (in Billion US$), 2003-2007
Figure 3-20: Germany - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-21: France - Pharmaceutical Market (in Billion US$), 2006 & 2007
Figure 3-22: France - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-23: Italy - Pharmaceutical Market (in Billion US$), 2003-2007
Figure 3-24: Italy - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-25: Spain - Pharmaceutical Market* (in Billion €), 2004-2007
Figure 3-26: Spain - Pharmaceutical Market Breakup in Prescription & OTC (%), 2006
Figure 3-27: Spain - Pharmaceutical Sales through Pharmacies by Therapeutic Class (%), 2006
Figure 3-28: Spain - Forecast for Pharmaceutical Market (in Billion €), 2008-2012
Figure 3-29: UK - Pharmaceutical Market (in Billion ¡ê), 2005-2007
Figure 3-30: UK - Forecast for Pharmaceutical Market (in Billion ¡ê), 2008-2012
Figure 3-31: Russia - Pharmaceutical Market* (in Billion US$), 2006 & 2007
Figure 3-32: Russia - Breakup of Pharmaceutical Market (%), 2007
Figure 3-33: Russia - Share of Imported & Domestically-produced Pharmaceutical Sales (%), 2007
Figure 3-34: Russia - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-35: Turkey - Pharmaceutical Market (in Billion €), 2003-2007
Figure 3-36: Turkey - Generics & Reference Market (in Billion €), 2003-2007
Figure 3-37: Turkey - Pharmaceutical Consumption by Therapeutic Class (%), 2007
Figure 3-38: Turkey - Share of Imported & Domestically-produced Pharmaceutical Sales (%), 2007
Figure 3-39: Turkey - Forecast for Pharmaceutical Market (in Billion €), 2008-2012
Figure 3-40: Poland - Pharmaceutical Market (in Billion €), 2006 & 2007
Figure 3-41: Poland - Forecast for Pharmaceutical Market (in Billion €), 2008-2012
Figure 3-42: Hungary - Pharmaceutical Market (in Billion US$), 2003-2007
Figure 3-43: Hungary - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-44: Ukraine - Pharmaceutical Market (in Billion US$), 2003-2007
Figure 3-45: Ukraine - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-46: Czech Republic - Pharmaceutical Market (in Billion US$), 2003-2007
Figure 3-47: Czech Republic - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-48: Romania - Pharmaceutical Market (in Billion €), 2004-2007
Figure 3-49: Romania - Forecast for Pharmaceutical Market (in Billion €), 2008-2012
Figure 3-50: Asia-Pacific - Pharmaceutical Market (in Billion US$), 2006 & 2007
Figure 3-51: Asia-Pacific - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-52: India - Pharmaceutical Market (in Billion US$), 2006 & 2007
Figure 3-53: India - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-54: China - Pharmaceutical Market (in Billion US$), 2005-2007
Figure 3-55: China - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-56: Japan - Pharmaceutical Market (in Billion US$), 2006 & 2007
Figure 3-57: Japan - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-58: South Korea - Pharmaceutical Market* (in Billion US$), 2003-2007
Figure 3-59: South Korea - Forecast for Pharmaceutical Market* (in Billion US$), 2008-2012
Figure 3-60: Indonesia - Pharmaceutical Market (in Billion US$), 2006E & 2007
Figure 3-61: Indonesia - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-62: Vietnam - Pharmaceutical Market (in Million US$), 2006E & 2007
Figure 3-63: Vietnam - Forecast for Pharmaceutical Market (in Million US$), 2008-2012
Figure 3-64: Thailand - Pharmaceutical Market (in Billion ?), 2006 & 2007
Figure 3-65: Thailand - Forecast for Pharmaceutical Market (in Billion ?), 2008-2012
Figure 3-66: Philippines - Pharmaceutical Market (in Billion US$), 2006E & 2007
Figure 3-67: Philippines - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-68: Malaysia - Pharmaceutical Market (in Million US$), 2006E & 2007
Figure 3-69: Malaysia - Forecast for Pharmaceutical Market (in Million US$), 2008-2012
Figure 3-70: Saudi Arabia - Pharmaceutical Market (in Billion SR), 2006 & 2007
Figure 3-71: Saudi Arabia - Share of Imported & Domestically-produced Pharmaceutical Sales (in Billion SR), 2004-2007
Figure 3-72: Saudi Arabia - Forecast for Pharmaceutical Market (in Billion SR), 2008-2012
Figure 3-73: UAE - Pharmaceutical Market (in Billion US$), 2004 & 2007
Figure 3-74: UAE - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-75: Australia - Pharmaceutical Market (in Billion US$), 2003-2007
Figure 3-76: Australia - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-77: New Zealand - Pharmaceutical Market (in Million US$), 2003-2007
Figure 3-78: New Zealand - Forecast for Pharmaceutical Market (in Million US$), 2008-2012
Figure 3-79: South Africa - Pharmaceutical Market (in Billion US$), 2005-2007
Figure 3-80: South Africa - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-81: Egypt - Pharmaceutical Market (in Billion US$), 2004-2007
Figure 3-82: Egypt - Forecast for Pharmaceutical Market (in Billion US$), 2008-2012
Figure 3-83: Nigeria - Pharmaceutical Market (in Million US$), 2006E & 2007
Figure 3-84: Nigeria - Forecast for Pharmaceutical Market (in Million US$), 2008-2012

Tables

Table 2-1: Global - Pharmaceutical Market by Region (in Billion US$), 2007
Table 2-2: Global - Leading Therapy Classes by Sales (in Billion US$), 2007
Table 2-3: Global - Leading Drugs by Sales (in Billion US$), 2007
Table 3-1: US - Healthcare Statistics (2003-2007)
Table 3-2: US - Forecast for Healthcare Statistics (2008-2012)
Table 3-3: Canada - Healthcare Statistics (2003-2007)
Table 3-4: Canada - Forecast for Healthcare Statistics (2008-2012)
Table 3-5: Brazil - Healthcare Statistics (2003-2007)
Table 3-6: Brazil - Forecast for Healthcare Statistics (2008-2012)
Table 3-7: Mexico - Healthcare Statistics (2003-2007E)
Table 3-8: Mexico - Forecast for Healthcare Statistics (2008-2012)
Table 3-9: Argentina - Healthcare Statistics (2003-2007)
Table 3-10: Argentina - Forecast for Healthcare Statistics (2008-2011)
Table 3-11: Chile - Healthcare Statistics (2003-2007)
Table 3-12: Chile - Forecast for Healthcare Statistics (2008-2012)
Table 3-13: Germany - Healthcare Statistics (2003-2007)
Table 3-14: Germany - Forecast for Healthcare Statistics (2008-2012)
Table 3-15: France - Healthcare Statistics (2003-2007)
Table 3-16: France - Forecast for Healthcare Statistics (2008-2012)
Table 3-17: Italy - Healthcare Statistics (2003-2007)
Table 3-18: Italy - Forecast for Healthcare Statistics (2008-2012)
Table 3-19: Spain - Healthcare Statistics (2003-2007)
Table 3-20: Spain - Forecast for Healthcare Statistics (2008-2012)
Table 3-21: UK - Healthcare Statistics (2003-2007)
Table 3-22: UK - Forecast for Healthcare Statistics (2008-2012)
Table 3-23: Russia - Healthcare Statistics (2003-2007)
Table 3-24: Russia - Forecast for Healthcare Statistics (2008-2012)
Table 3-25: Turkey - Healthcare Statistics (2003-2007)
Table 3-26: Turkey - Forecast for Healthcare Statistics (2008-2012)
Table 3-27: Poland - Healthcare Statistics (2003-2007)
Table 3-28: Poland - Forecast for Healthcare Statistics (2008-2012)
Table 3-29: Hungary - Healthcare Statistics (2003-2007)
Table 3-30: Hungary - Forecast for Healthcare Statistics (2008-2012)
Table 3-31: Ukraine - Healthcare Statistics (2003-2007)
Table 3-32: Ukraine - Forecast for Healthcare Statistics (2008-2012)
Table 3-33: Czech Republic - Healthcare Statistics (2003-2007)
Table 3-34: Czech Republic - Forecast for Healthcare Statistics (2008-2012)
Table 3-35: Romania - Healthcare Statistics (2003-2007)
Table 3-36: Romania - Forecast for Healthcare Statistics (2008-2012)
Table 3-37: India - Healthcare Statistics (2003-2007)
Table 3-38: India - Forecast for Healthcare Statistics (2008-2012)
Table 3-39: China - Healthcare Statistics (2003-2007)
Table 3-40: China - Forecast for Healthcare Statistics (2008-2012)
Table 3-41: Japan - Healthcare Statistics (2003-2007)
Table 3-42: Japan - Forecast for Healthcare Statistics (2008-2012)
Table 3-43: South Korea - Healthcare Statistics (2003-2007)
Table 3-44: South Korea - Forecast for Healthcare Statistics (2008-2012)
Table 3-45: Indonesia - Healthcare Statistics (2003-2007)
Table 3-46: Indonesia - Forecast for Healthcare Statistics (2008-2012)
Table 3-47: Vietnam - Healthcare Statistics (2003-2007)
Table 3-48: Vietnam - Forecast for Healthcare Statistics (2008-2012)
Table 3-49: Thailand - Healthcare Statistics (2003-2007)
Table 3-50: Thailand - Forecast for Healthcare Statistics (2008-2012)
Table 3-51: Philippines - Healthcare Statistics (2003-2007)
Table 3-52: Philippines - Forecast for Healthcare Statistics (2008-2012)
Table 3-53: Malaysia - Healthcare Statistics (2003-2007)
Table 3-54: Malaysia - Forecast for Healthcare Statistics (2008-2012)
Table 3-55: Saudi Arabia - Healthcare Statistics (2003-2007)
Table 3-56: Saudi Arabia - Forecast for Healthcare Statistics (2008-2012)
Table 3-57: Australia - Healthcare Statistics (2003-2007)
Table 3-58: Australia - Forecast for Healthcare Statistics (2008-2012)
Table 3-59: New Zealand - Healthcare Statistics (2003-2007)
Table 3-60: New Zealand - Forecast for Healthcare Statistics (2008-2012)
Table 3-61: South Africa - Healthcare Statistics (2003-2007)
Table 3-62: South Africa - Forecast for Healthcare Statistics (2008-2012)
Table 3-63: Egypt - Healthcare Statistics (2003-2007)
Table 3-64: Egypt - Forecast for Healthcare Statistics (2008-2012)
Table 3-65: Nigeria - Healthcare Statistics (2003-2007)
Table 3-66: Nigeria - Forecast for Healthcare Statistics (2008-2012)
Table 4-1: Pfizer Inc - Key Financials (in Million US$), 2005-2007
Table 4-2: Pfizer Inc - Strengths & Weaknesses
Table 4-3: Sanofi-Aventis - Key Financials (in Million €), 2005-2007
Table 4-4: Sanofi-Aventis - Strengths & Weaknesses
Table 4-5: GlaxoSmithKline plc - Key Financials (in Million ¡ê), 2005-2007
Table 4-6: GlaxoSmithKline plc - Strengths & Weaknesses
Table 4-7: Novartis International AG - Key Financials (in Million US$), 2005-2007
Table 4-8: Novartis International AG - Strengths & Weaknesses
Table 4-9: AstraZeneca Plc - Key Financials (in Million US$), 2005-2007
Table 4-10: AstraZeneca Plc - Strengths & Weaknesses